Research And Development Drive Growth In The Pharmacovigilance Market Is Supporting Development Across The Pharmacovigilance Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Pharmacovigilance Market Increase Between 2026 And 2030?

The pharmacovigilance market size has shown rapid expansion in recent years. Its value is anticipated to increase from $9.64 billion in 2025 to $10.86 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.7%. Historically, this market’s growth has been fueled by an increase in adverse drug reaction reporting, wider global pharmaceutical approvals, a rise in clinical trial volumes, the establishment of international drug safety regulations, and greater usage of drugs for chronic diseases.

The pharmacovigilance market is projected to experience substantial expansion over the upcoming years. By 2030, its valuation is anticipated to reach $17.41 billion, driven by a compound annual growth rate (CAGR) of 12.5%. This expansion during the projection period stems from factors such as increased use of real-world data, a rise in approvals for biologics and biosimilars, the growing intricacy of combination therapies, the widening scope of pharmacovigilance in developing regions, and a heightened emphasis on patient safety results. Key developments expected during this timeframe involve the broadening of post-marketing surveillance, a greater uptake of real-world evidence in safety assessments, intensified regulatory oversight and adherence demands, an increase in the outsourcing of pharmacovigilance functions, and the consolidation of safety data from multiple sources.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

Which Growth Drivers Are Expected To Support The Pharmacovigilance Market Forward?

Rising research and development endeavors are set to propel the pharmacovigilance market. Through investments in R&D, pharmaceutical firms are able to create novel and advanced medications possessing enhanced safety characteristics. Thorough preclinical and clinical trials conducted during the drug development lifecycle facilitate the prompt identification of possible safety issues, enabling the deployment of suitable risk reduction strategies. Moreover, R&D initiatives aid in evolving technologies for tracking adverse events, analyzing data, and identifying signals, thereby assisting in the swift detection of undesirable drug reactions post-marketing. For example, in 2023, the Office for National Statistics, a UK-based government agency, reported that the UK government’s net expenditure on research and development (R&D) climbed to £17.4 billion in 2023, an increase from £16.1 billion in 2022, signifying an 8.2% surge. Consequently, the escalating research and development activities have bolstered the expansion of the pharmacovigilance market.

Which Segment Groups Define The Pharmacovigilance Market Landscape?

The pharmacovigilance market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

2) By Service Provider: In-House, Contract Outsourcing

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

What Trends Are Affecting The Pharmacovigilance Market Dynamics?

Leading companies within the pharmacovigilance market are increasingly directing their focus towards artificial intelligence (AI) to enhance operational efficiency. AI is instrumental in boosting the effectiveness and precision of pharmacovigilance activities, ultimately contributing to improved patient outcomes. By integrating AI, pharmaceutical enterprises can streamline their processes, refine data management, and accelerate drug discovery, concurrently achieving cost reductions and heightened safety. An illustrative example occurred in August 2024, when the Government of India introduced the Adverse Drug Reaction Monitoring System (ADRMS) software, launched by the Minister of Health & Family Welfare and Minister of Chemicals and Fertilizers. This specialized pharmacovigilance software facilitates the systematic gathering and analysis of adverse events associated with medicines and medical devices, thereby simplifying the reporting process for both consumers and healthcare professionals. This endeavor considerably fortifies India’s pharmacovigilance infrastructure by ensuring a more thorough acquisition of safety data and elevating drug safety monitoring. The ADRMS is designed to improve the efficiency of drug safety oversight and compliance with established standards, aiming to position India as a pivotal leader in the global pharmaceutical industry.

Which Organizations Are Involved In The Pharmacovigilance Market?

Major companies operating in the pharmacovigilance market are IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation, United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Secure AI Labs, OmniSol dot Tech, Prevnos Inc., Lifescient Inc, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., Novasyte, Fortrea Holdings Inc., Syneos Health Clinical, Telerx Marketing Inc.

Access The Complete Pharmacovigilance Market Report:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

What Is The Largest Regional Market In The Pharmacovigilance Market?

North America was the largest region in the pharmacovigilance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pharmacovigilance Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

Browse Through More Reports Similar to the Global Pharmacovigilance Market 2026, By The Business Research Company

Pharmacovigilance Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Medical Devices Vigilance Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-devices-vigilance-global-market-report

Cosmetovigilance Market Report 2026

https://www.thebusinessresearchcompany.com/report/cosmetovigilance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795